0001127602-23-020573.txt : 20230711 0001127602-23-020573.hdr.sgml : 20230711 20230711173514 ACCESSION NUMBER: 0001127602-23-020573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230707 FILED AS OF DATE: 20230711 DATE AS OF CHANGE: 20230711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Loose Christopher R. CENTRAL INDEX KEY: 0001785299 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 231082864 MAIL ADDRESS: STREET 1: C/O FREQUENCY THERAPEUTICS, INC. STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-07-07 0001703647 Frequency Therapeutics, Inc. FREQ 0001785299 Loose Christopher R. C/O FREQUENCY THERAPEUTICS, INC. 75 HAYDEN AVE, SUITE 300 LEXINGTON MA 02421 1 Chief Scientific Officer 1 Common Stock 2023-07-07 4 S 0 1306 .36 D 62781 D Common Stock 2023-07-07 4 M 0 4546 A 67327 D Common Stock 2023-07-10 4 S 0 1304 .37 D 66023 D Common Stock 2023-07-10 4 M 0 4546 A 70569 D Restricted Stock Unit 2023-07-07 4 M 0 4546 D Common Stock 4546 136362 D Restricted Stock Unit 2023-07-10 4 M 0 4546 D Common Stock 4546 131816 D Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.34 to $0.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Includes 6,329 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2023. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The restricted stock units will fully vest on July 4, 2023. /s/ James P. Abely, Attorney-in-Fact for Christopher R. Loose 2023-07-11